Early in Biological Technology

Genomic Health Reports Favorable Commentary on Value of Multigene Assays From the St. Gallen Expert Consensus Meeting on the Primary Treatment of Early Breast Cancer

- Guidelines Specify that Validated Molecular Assays Should be Considered as an Adjunct to Standard Measures in Helping Determine Chemotherapy Benefit - GENEVA, and REDWOOD CITY, Calif., June 26 /PRNewswire-FirstCall/ -- Genomic Health, Inc. (Nasdaq: GHDX ) today reported that the St. Galle...

Scientists identify gene vital to early embryonic cells forming a normal heart and skull

New research from Cincinnati Children's Hospital Medical Center highlights the critical role a certain gene and its protein play during early embryonic development on formation of a normal heart and skull. In a study posted online June 15 by the Proceedings of the National Academy of Sciences ...

Debiopharm Group and Moffitt Cancer Center Sign Development and Commercialisation Agreement for Small Molecule Debio 0928 in Early Preclinical Development for Treatment of Solid Tumours

LAUSANNE, Switzerland and TAMPA, Florida, June 18 /PRNewswire/ -- Debiopharm Group (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, and Moffitt Cancer Center (Moffitt), a non-profit Fl...

LNA-Based HIF-1 Alpha Inhibitor Shows Early Signs of Clinical Benefit

COPENHAGEN, June 4 /PRNewswire/ -- Santaris Pharma today announced that the cancer drug EZN-2968 - an inhibitor of HIF-1alpha, jointly developed by Enzon Pharmaceuticals and Santaris Pharma A/S - was well tolerated and showed early signs of clinical benefit in previously treated cancer patient...

Novavax Announces Early Retirement of $17 Million of Convertible Debt

Transaction removes significant financial obligation and improves balance sheet ROCKVILLE, Md., April 29 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX ), a leader in the development of novel vaccines, today announced that it has reached an early payoff agreement with holders of $17 ...

PAREXEL Experts to Address Benefits of Rigorous Early Phase Development at Annual ASCPT Meeting

BOSTON, March 16 /PRNewswire/ -- PAREXEL experts will address the benefits of rigorous early phase clinical development at the 110th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics (ASCPT), to be held at the Gaylord National Resort in National Harbor, Maryland fro...

Covance Increases Early Clinical Footprint in Europe with Acquisition of Swiss-Based Early Clinical Development Site

PRINCETON, N.J., March 13 /PRNewswire-FirstCall/ -- Covance Inc. (NYSE: CVD ) announced today that it is expanding its clinical pharmacology footprint in Europe with the acquisition of Swiss Pharma Contract, a 50-bed clinical research company based in Basel, Switzerland. "Our clients' need ...

Further 100 Million Euros Allocated to Netherlands-Based R&D Targeting the Early Diagnosis and Treatment of Disease

EINDHOVEN, The Netherlands, March 10 /PRNewswire/ -- The Center for Translational Molecular Medicine (CTMM) - the Dutch public-private partnership committed to the research and development of new techniques for the diagnosis and treatment of major diseases - today announced that eight new rese...

Index Ventures Closes Euro 350 Million Early Stage Fund

Ben Holmes Named Partner LONDON, March 3 /PRNewswire/ -- Index Ventures today announced the closing of a euro 350 million early stage fund, Index Ventures V. The fund is dedicated to early stage and seed investments in the technology, biotechnology and clean technology sectors across Europ...

Frost & Sullivan Forecasts Early Rebound: Strong Growth Ahead for Global Economy

MOUNTAIN VIEW, Calif., Feb. 17 /PRNewswire/ -- Frost & Sullivan, the Growth Partnership Company, reaffirms its position that the economy is regaining its strength, thanks in part to an unprecedented US $1 trillion stimulus package from the US government and additional stimulus packages fro...

SMU chemist wins NSF early career award

DALLAS -- Southern Methodist University chemist Brent Sumerlin has earned a National Science Foundation Faculty Early Career Development Award, given to junior faculty members who exemplify the role of teacher-scholars in American colleges and universities. Sumerlin, assistant professor in the ...

Cryoablation of Early Invasive Ductal Breast Cancer With MRI Confirmation Shows Promising Clinical Benefits, According to Study Presented at RSNA

CHICAGO, Dec. 5 /PRNewswire/ -- Early clinical experience with the FDA cleared Visica 2(TM) Treatment System from Sanarus Medical confirms the effectiveness of ultrasound guided cryoablation to completely eradicate small, unifocal Invasive Ductal Breast Cancer (IDC). Initial data from this multi-...

RVX-208 Exploratory Study Illustrates Early Potential for Alzheimer's Disease

First in class drug illustrates early signal of transport of key amyloid marker from brain TSX Exchange Symbol: RVX CALGARY, Nov. 10 /PRNewswire-FirstCall/ - Resverlogix Corp. ("Resverlogix") (TSX:RVX) announced today that treatment with its lead drug RVX-208, a first in class ApoA-I/Prebet...

BSP Signs Agreement With CMP Trading for Distribution of HyperQ(TM) Stress System, for Early Detection of Ischemic Heart Disease, in South Korea

CMP Will Purchase at Least 227 HyperQ(TM) Systems During the Term of the Agreement TEL AVIV, Israel, November 10 /PRNewswire-FirstCall/ -- BSP (Biological Signal Processing Ltd.) ( http://www.bsp.co.il/ ), an Israeli company that develops and markets innovative sy...

Chiltern Early Phase: Fully Integrated and Business Ready

LONDON, Aug. 27 /PRNewswire/ -- Following the successful acquisition of Drug Development Solutions ('DDS') in February, Chiltern, a leading contract research organization, announced today that it has fully integrated its two early Phase units into a single operation branded as Chiltern Early P...

Chest Physicians Now Suggest Early Intervention for Certain Blood Clots in DVT

2008 American College of Chest Physicians (ACCP) Guidelines Will Increase Use of Trellis(R) Peripheral Infusion System NORTHBROOK, Ill., July 29 /PRNewswire/ -- The American College of Chest Physicians (ACCP) has published new evidence-based clinical guidelines for physicians that ...

Nano-sized electronic circuit promises bright view of early universe

NEW BRUNSWICK, N.J. A newly developed nano-sized electronic device is an important step toward helping astronomers see invisible light dating from the creation of the universe. This invisible light makes up 98% of the light emitted since the "big bang," and may provide insights into the earliest ...

New MedPredict Report Highlights Trend Toward Early Diagnosis and Treatment of Rheumatoid Arthritis, Impact on Pharmaceutical Development

SCOTTSDALE, Ariz., July 8 /PRNewswire/ -- MedPredict Market Research, a global provider of pharmaceutical competitive intelligence and market research, has published a new report providing critical strategic insight for pharma and biotech companies with a stake in the market for Rheumatoid Art...

Dow AgroSciences Announces Early Exercise of Option for Commercial License With Sangamo BioSciences for Plants

Dow AgroSciences Will Sublicense Sangamo's Technology in Plant Agriculture Under the Trademark EXZACT(TM) Precision Traits SAN DIEGO, June 18 /PRNewswire-FirstCall/ -- Dow AgroSciences LLC, a wholly owned subsidiary of The Dow Chemical Company (NYSE: DOW ), announced today at the 20...

PAREXEL Enhances Early Phase Clinical Development Offering for Central Nervous System Studies

BOSTON, June 17 /PRNewswire-FirstCall/ -- PAREXEL International Corporation (Nasdaq: PRXL ), a leading global biopharmaceutical services provider, today announced that it is expanding its clinical pharmacology capabilities in the Central Nervous System (CNS) therapeutic area. PAREXEL is enhan...

First semiconductor-based PET scanner demonstrates potential to aid in early diagnosis of disease

NEW ORLEANS, La.Evaluations of the first-ever prototype positron emission tomography (PET) brain scanner that uses semiconductor detectors indicate that the scanner could advance the quality and spatial resolution of PET imaging, according to researchers at SNM's 55th Annual Meeting. The prototype...

Video: Higher Initial Dose of Gleevec Achieved Better Early Responses than Standard Dose for Patients with Chronic Myeloid Leukemia

- Efficacy and safety profile in large randomized Phase III study consistent with landmark IRIS trial, which established Gleevec as standard of care - Study did not meet primary endpoint at 1 year, yet shows faster time to molecular responses with...

First Taxane-Based Non-Anthracycline Containing Chemotherapy in Combination With Herceptin (TCH) for HER2 Positive Early Breast Cancer Patients Obtains Approval From the FDA

TCH (Taxotere, Carboplatin, Herceptin) showed a significant improvement in Disease-Free Survival (DFS) and Overall Survival (OS), compared to AC-T (doxorubicin and cyclophosphamide followed by docetaxel) and a 5-fold lower cardiotoxicity compared to AC-TH (AC-T + Herceptin) in women receivin...

Genetic Engineering and Biotechnology News (GEN) Reports on Early ADMET Use

NEW ROCHELLE, N.Y., May 5 /PRNewswire/ -- Biotech and pharma companies are increasingly utilizing novel technologies to assess the druggability of test compounds early in the development cycle to avoid costly late clinical-stage attrition, according to Genetic Engineering and Biotechnology New...

Increased Light Leads to Early Detection: Caliper Life Sciences Introduces Bioware(R) Ultra Cancer Cell Lines

-Researchers Now Able to Detect a Single Cancer Cell Through In Vivo Imaging- HOPKINTON, Mass., April 15 /PRNewswire-FirstCall/ -- Caliper Life Sciences, Inc. (Nasdaq: CALP ) today introduced Bioware(R) Ultra cell lines, a range of ultra bright light producing...

Canadian Centre for DNA Barcoding to Participate in Microchip Biotechnologies Early Access Program for Microchip-Based DNA Sample Preparation and Cycle Sequencing

DUBLIN, Calif., April 8, 2008 /PRNewswire/ -- Microchip Biotechnologies, Inc. (MBI) is pleased to announce that the Canadian Centre for DNA Barcoding (CCDB), at the Biodiversity Institute of Ontario, University of Guelph, will be the first participant to join MBI's early access program for the...

JCI online early table of contents: March 6, 2008

EDITOR'S PICK: Pinpoint accuracy: DNA vaccines that home in on DCs are more potent One strategy being pursued to develop new vaccines against infectious diseases is DNA vaccination. The idea is that following administration of a DNA vaccine, the body converts the information in the DNA vaccin...

New Independent Research Study Indicates That Cylex's ImmuKnow Test May Identify Kidney Transplant Patients at Risk for Early Acute Rejection

COLUMBIA, Md., Feb. 20 /PRNewswire/ -- Cylex, Inc., today announced the publication of an independent, peer reviewed, clinical research study in which the level of cellular immune response measured prior to kidney transplantation using the Company's proprietary ImmuKnow(R) immune cell function...

Campbell Alliance Brand Management and Managed Markets Practices to Speak at CBI's Early Commercialization Conference

RALEIGH, N.C., Feb. 19 /PRNewswire/ -- Campbell Alliance, the leading management consulting firm specializing in the pharmaceutical and biotech industry, today announced that executives from its Brand Management and Managed Markets practices will present at the 4th Annual Forum on Early Stage ...

New Technology for Early Detection of Lung Cancer Selected for Clinical Study With Veterans

New Mexico Department of Veterans Services Partners with New Mexico Tech and Biomoda, Inc. ALBUQUERQUE, N.M., Feb. 14 /PRNewswire-FirstCall/ -- The New Mexico Institute of Mining and Technology (New Mexico Tech) and Biomoda, Inc. (OTC Bulletin Board: BMOD) (http://ww...

Biomoda and Medical Acoustics Partner in Study for Early Detection of Lung Cancer in Veterans

Innovative Lung Flute(R) to be used to provide cost-efficient, easy to use method of collecting lung sputum samples for testing ALBUQUERQUE, N.M., Feb. 13 /PRNewswire-FirstCall/ -- Biomoda, Inc. (OTC Bulletin Board: BMOD), a maker of patented early lung cancer detection testing and oth...

Solstice Neurosciences, Inc. Issues Corporate Response to FDA Early Communication

MALVERN, Pa., Feb. 8 /PRNewswire/ -- Safety of patients treated with Myobloc(R) (Botulinum Toxin Type B) Injectable Solution has always been of primary importance for Solstice Neurosciences, Inc. ("Solstice"). We support education and training of physicians in a number of ways regarding the pr...

Montana State University lab gives early warnings about biological invaders

BOZEMAN, Mont. -- Montanans don't think a lot about "Homeland Security," but one Montana State University unit that serves both ag producers and home gardeners also serves to keep us safe from other biological invaders. The Schutter Diagnostic Lab on the Bozeman campus recently received a five-...

Medicsight Welcomes U.S. Initiative to Reimburse CT Colonography for Early Detection of Colorectal Cancer

NEW YORK, Dec. 21 /PRNewswire-FirstCall/ -- Medicsight PLC, a subsidiary of MGT Capital Investments, Inc. (Amex: MGT ), and an industry leader in the development of Computer-Aided Detection (CAD) and image analysis software which assists in the early detection of disease, welcomes the initiat...

DermTech Is Issued U.S. Patent for the Early Detection, Staging and Monitoring of Melanoma

LA JOLLA, Calif., Dec 19 /PRNewswire/ -- DermTech, Inc., a biotechnology company developing molecular diagnostics for the early detection of melanoma and other diseases, announced that it has been issued Patent No. 7,297,480 by the United States Patent and Trademark Office. The patent, entitle...

A&G Pharmaceutical Receives $870,000 Grant from Avon Foundation to Advance Innovative Blood Diagnostic Test for Early Detection of Breast Cancer

COLUMBIA, Md., Dec. 14 /PRNewswire/ -- A&G Pharmaceutical announced today that the Avon Foundation Breast Cancer Prevention Research Initiative has awarded A&G an $870,000 grant to conduct multicenter clinical studies focused on measuring levels of A&G's proprietary breast cancer biomarker, GP...

Multigene Test Predicts Who Could Avoid Chemotherapy Despite Positive Lymph Nodes in Early Breast Cancer

SAN ANTONIO, Texas, Dec. 13 /PRNewswire/ -- Kathy S. Albain, MD, of Loyola University Chicago, presented new data showing for the first time the predictive value of the 21-gene Recurrence Score (RS) assay in patients with node-positive breast cancer. The Breast Cancer Intergroup of North Ameri...

Taxotere(R)-Based Chemotherapy Significantly Improved Overall Survival Compared With Standard Anthracycline-Based Chemotherapy in Early Stage Breast Cancer

Oral Presentation of the US Oncology Adjuvant Trial 9735 at 2007 San Antonio Breast Cancer Symposium Showed Taxotere(R) and Cyclophosphamide Improved Overall Survival Versus An Anthracycline Combination SAN ANTONIO, Dec. 13 /PRNewswire-FirstCall/ -- Results presented at the 30th annual...

The Tauri Group LLC Awarded U.S. Department of Homeland Security Chemical and Biological Early Detection Systems Program Office Support Contract

ALEXANDRIA, Va., Dec. 11 /PRNewswire/ -- The Tauri Group LLC is pleased to announce that it has been selected to provide Systems Engineering and Technical Assistance (SETA) support for the U.S. Department of Homeland Security (DHS) Office of Health Affairs Early Detection Division Chemical and...

New technique can be breakthrough for early cancer diagnosis

Early detection of disease is often critical to how successful treatment can be. Therefore, the development of new methods of diagnosis is a hot research field, where every small step is of great importance. In an article in the latest issue of Molecular & Cellular Proteomics, Uppsala University...